ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
Go back to ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 9.67 +0.64 (7.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.03 | 52 Week High | $2.18 | |||
| Open | $9.43 | 52 Week Low | $0.30 | |||
| Day High | $9.69 | P/E | N/A | |||
| Day Low | $9.36 | EPS | $-3.32 | |||
| Volume | 531,831 | |||||
| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 9.67 +0.64 (7.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.03 | 52 Week High | $2.18 | |||
| Open | $9.43 | 52 Week Low | $0.30 | |||
| Day High | $9.69 | P/E | N/A | |||
| Day Low | $9.36 | EPS | $-3.32 | |||
| Volume | 531,831 | |||||



